Effect of Pravastatin on Experimental Diabetic Wound Healing

Journal of Surgical Research

Volumn 161, Issue 2, 2010, Pages 336-340

  Laing, Tereze ^a   Hanson, Richard ^a   Chan, Fuan ^a   Bouchier Hayes, David ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

diabetes; eNOS; nitric oxide; statins; wound healing

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYPROLINE; NITRATE; NITRIC OXIDE; NITRITE; PRAVASTATIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; UPREGULATION; WOUND HEALING IMPAIRMENT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYDROXYPROLINE; MALE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; PRAVASTATIN; RATS; RATS, SPRAGUE-DAWLEY; SKIN; WOUND HEALING; WOUNDS AND INJURIES;

EID: 77951939163     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.01.024     Document Type: Article

References (43)

1. Nathan D.M. Long-term complications of diabetes mellitus. N Engl J Med 328 (1993) 1676
2. World Health Organization. Diabetes: Facts and figures. Fact sheet no 312. September 2006.
3. Saaristo A., Tammela T., Farkkila A., et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol 169 (2006) 1080
4. Chesnoy S., Lee P.Y., and Huang L. Intradermal injection of transforming growth factor-beta1 gene enhances wound healing in genetically diabetic mice. Pharm Res 20 (2003) 345
5. Embil J., and Nagai M. Becaplermin: Recombinant platelet-derived growth factor, a new treatment for healing diabetic foot ulcers. Exp Opin Biol Ther 2 (2002) 211
6. Embil J.M., Papp K., Sibbald G., et al. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: An open-label clinical evaluation of efficacy. Wound Repair Regen 8 (2000) 162
7. Cavallini M. Autologous fibroblasts to treat deep and complicated leg ulcers in diabetic patients. Wound Repair Regen 15 (2007) 35
8. Ehrenreich M., and Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Eng 12 (2006) 2407
9. Lobmann R., Pittasch D., Mühlen I., et al. Autologous human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid for grafting in nonhealing diabetic foot lesions: A pilot study. J Diabetes Complications 17 (2003) 199
10. Komesu M.C., Tanga M.B., Buttros K.R., et al. Effects of acute diabetes on rat cutaneous wound healing. Pathophysiology 11 (2004) 63
11. Rizk M., Witte M.B., and Barbul A. Nitric oxide and wound healing. Review. World J Surg 28 (2004) 301 Epub 2004 Feb 17
12. Schwentker A., and Billiar T.R. Nitric oxide and wound repair. Review. Surg Clin North Am 83 (2003) 521
13. Schaffer M.R., Tantry U., Efron P.A., et al. Diabetes-impaired healing and reduced wound nitric oxide synthesis: A possible pathophysiologic correlation. Surgery 121 (1997) 513
14. Shi H.P., Efron D.T., Most D., et al. Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice. Surgery 128 (2000) 374
15. Shi H.P., Most D., Efron D.T., et al. Supplemental L-arginine enhances wound healing in diabetic rats. Wound Repair Regen 11 (2003) 198
16. Luo J.D., Wang Y.Y., Fu W.L., et al. Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice. Circulation 110 (2004) 2484
17. Briel M., Schwartz G.G., Thompson P.L., et al. Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: A meta-analysis of randomized controlled trials. JAMA 295 (2006) 2046
18. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 339 (1998) 1349
19. Paraskevas K., Hamilton G., and Mikhailidis D. Statins: An essential component in the management of carotid artery disease. J Vasc Surg 46 (2007) 373
20. Paciaroni M., Hennerici M., Agnelli G., et al. Statins and stroke prevention. Cerebrovasc Dis 24 (2007) 170
21. Laufs U. Beyond lipid-lowering: Effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol 58 (2003) 719
22. Hyde R.J., and Bell R.H. Animal models of diabetes mellitus: Physiology and pathology. J Surg Res 35 (1983) 433
23. Dorsett-Martin W.A. Rat models of skin wound healing: A review. Wound Repair Regen 12 (2004) 591
24. Barbul A., and Efron D.T. Subcutaneous sponge models. Methods Mol Med 78 (2003) 83
25. He L.K., and Gamelli R.L. Incisional wound healing. Model and analysis of wound breaking strength. Methods Mol Med 78 (2003) 37
26. Woessner J. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93 (1961) 440
27. Luo G., Peng D., Zheng J., et al. The role of NO in macrophage dysfunction at early stage after burn injury. Burns 31 (2005) 138
28. Lee R.H., Efron D., Tantry U., et al. Nitric oxide in the healing wound: A time-course study. J Surg Res 101 (2001) 104
29. Boulton A., Vileikyte L., Ragnarson-Tennvall G., et al. The global burden of diabetic foot disease. Lancet 366 (2005) 1719
30. Wolffenbuttel B., Boulanger C., Crijns F., et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95 (1998) 4630
31. Plouffe J., Silva J., Fekety R., et al. Cell-mediated immunity in diabetes mellitus. Infect Immun 21 (1978) 425
32. Faustman D., Eisenbarth G., Daley J., et al. Abnormal T-lymphocyte subsets in type I diabetes. Diabetes 38 (1989) 1462
33. Rubinstein A., and Pierce C. Rapid healing of diabetic foot ulcers with meticulous blood glucose control. Acta Diabetol Lat 25 (1988) 25
34. Steed D. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 117 7 Suppl (2006) 143S
35. Witte M.B., Kiyama T., and Barbul A. Nitric oxide enhances experimental wound healing in diabetes. Br J Surg 89 (2002) 1594
36. Yamasaki K., Edington H., McClosky C., et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 101 (1998) 967
37. Brunetti N.D., Maulucci G., Casavecchia G.P., et al. Improvements in endothelium dysfunction in diabetics with statins: A randomized comparison of atorvastatin 20mg versus rosuvastatin 10 mg. J Intervent Cardiol 20 (2007) 481
38. Cakmak M., Tanriverdi H., Cakmak N., et al. Simvastatin may improve myocardial perfusion abnormality in slow coronary flow. Cardiology 110 (2008) 39
39. Davidson J.M. Animal models for wound repair. Arch Dermatol Res 290 Suppl (1998) S1
40. Trengrove N.J., Stacey M.C., MacAuley S., et al. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors. Wound Repair Regen 7 (1999) 442
41. Bitar M.S., and Labbad Z.N. Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. J Surg Res 61 (1996) 113
42. Stallmeyer B., Anhold M., Wetzler C., et al. Regulation of eNOS in normal and diabetes-impaired skin repair: Implications for tissue regeneration. Nitric Oxide 6 (2002) 168
43. Roberts A.B. Transforming growth factor-beta: Activity and efficacy in animal models of wound healing. Wound Repair Regen 3 (1995) 408